XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma (clinicaltrials.gov) - Sep 22, 2021 - P2; N=70; Completed; Sponsor: Chemlmmune Therapeutics LLC; Recruiting ➔ Completed
Clinical • Trial completion • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|